Intravenous Immunoglobulins Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4163075
- 91 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Intravenous Immunoglobulins market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Intravenous Immunoglobulins market segmented into
Neurology
Hematology
Immunology
Based on the end-use, the global Intravenous Immunoglobulins market classified into
Hospitals
Drugstore
Others
Based on geography, the global Intravenous Immunoglobulins market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
CSL Behring
Grifols
Octapharma
Shire
ADMA Biologics
Bayer
Bharat Serum and Vaccines
Biotest
China Biologic Products
Hualan Biological Engineering
Kedrion Biopharma
Sanquin
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS IMMUNOGLOBULINS INDUSTRY
2.1 Summary about Intravenous Immunoglobulins Industry
2.2 Intravenous Immunoglobulins Market Trends
2.2.1 Intravenous Immunoglobulins Production & Consumption Trends
2.2.2 Intravenous Immunoglobulins Demand Structure Trends
2.3 Intravenous Immunoglobulins Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Neurology
4.2.2 Hematology
4.2.3 Immunology
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Drugstore
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Neurology
5.2.2 Hematology
5.2.3 Immunology
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Drugstore
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Neurology
6.2.2 Hematology
6.2.3 Immunology
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Drugstore
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Neurology
7.2.2 Hematology
7.2.3 Immunology
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Drugstore
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Neurology
8.2.2 Hematology
8.2.3 Immunology
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Drugstore
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Neurology
9.2.2 Hematology
9.2.3 Immunology
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Drugstore
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 CSL Behring
10.1.2 Grifols
10.1.3 Octapharma
10.1.4 Shire
10.1.5 ADMA Biologics
10.1.6 Bayer
10.1.7 Bharat Serum and Vaccines
10.1.8 Biotest
10.1.9 China Biologic Products
10.1.10 Hualan Biological Engineering
10.1.11 Kedrion Biopharma
10.1.12 Sanquin
10.2 Intravenous Immunoglobulins Sales Date of Major Players (2017-2020e)
10.2.1 CSL Behring
10.2.2 Grifols
10.2.3 Octapharma
10.2.4 Shire
10.2.5 ADMA Biologics
10.2.6 Bayer
10.2.7 Bharat Serum and Vaccines
10.2.8 Biotest
10.2.9 China Biologic Products
10.2.10 Hualan Biological Engineering
10.2.11 Kedrion Biopharma
10.2.12 Sanquin
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Intravenous Immunoglobulins Product Type Overview
2.Table Intravenous Immunoglobulins Product Type Market Share List
3.Table Intravenous Immunoglobulins Product Type of Major Players
4.Table Brief Introduction of CSL Behring
5.Table Brief Introduction of Grifols
6.Table Brief Introduction of Octapharma
7.Table Brief Introduction of Shire
8.Table Brief Introduction of ADMA Biologics
9.Table Brief Introduction of Bayer
10.Table Brief Introduction of Bharat Serum and Vaccines
11.Table Brief Introduction of Biotest
12.Table Brief Introduction of China Biologic Products
13.Table Brief Introduction of Hualan Biological Engineering
14.Table Brief Introduction of Kedrion Biopharma
15.Table Brief Introduction of Sanquin
16.Table Products & Services of CSL Behring
17.Table Products & Services of Grifols
18.Table Products & Services of Octapharma
19.Table Products & Services of Shire
20.Table Products & Services of ADMA Biologics
21.Table Products & Services of Bayer
22.Table Products & Services of Bharat Serum and Vaccines
23.Table Products & Services of Biotest
24.Table Products & Services of China Biologic Products
25.Table Products & Services of Hualan Biological Engineering
26.Table Products & Services of Kedrion Biopharma
27.Table Products & Services of Sanquin
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Intravenous Immunoglobulins Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Intravenous Immunoglobulins Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Intravenous Immunoglobulins Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Intravenous Immunoglobulins Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
